Summary:
This podcast features a panel discussion on designing and developing drug delivery and devices for LMICs with representatives from Gilead Sciences, the Bill & Melinda Gates Foundation, ApiJect and AbbVie From the 2024 PODD: Partnership Opportunities in Drug Delivery.
The panelists discuss unique and compelling challenges of the last mile for LMICs, the role of pharma and medtech in the evolution of LMIC drug development, trends in the space, case studies of successful products and how to better consider cultural differences between LMICs and more developed markets.
To learn more about the PODD conference, please visit PODDConference.com.
Moderators
Monica Swinney, PhD
Senior Director, New Product Planning & Drug Delivery Innovation
Gilead Sciences
Panelists
Bo Kowalczyk, MBA
Chief Commercial Officer
ApiJect
Tycho Speaker, PhD
Sr Principal Research Scientist, Combination Product Development and Drug Delivery
AbbVie
Niya Bowers, PhD
Senior Program Officer
Bill & Melinda Gates Foundation
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.